Adverse Effects of ESWL: Incidence and Management
ESWL has fewer complications than percutaneous nephrolithotomy or ureteroscopy, with most adverse effects being mild (Clavien grade I-II in 18.43% of cases) and managed conservatively, though serious complications (Clavien grade III-IV) occur in 2.48% of patients. 1
Classification of Adverse Effects by Severity
Minor Complications (Clavien Grade I-II)
Stone Fragment-Related Complications:
- Colicky pain occurs in approximately 40% of patients and represents the most frequent complication 2
- Macroscopic hematuria develops in 17.2% of cases 1
- Steinstrasse (stone street formation) occurs in 4-24.2% of patients 1, 2
- Renal colic affects 2-4% of patients 1
- Residual fragment regrowth occurs in 21-59% of cases 1
Management of Minor Complications:
- Most minor complications resolve with conservative management or minimal intervention 2
- Medical expulsive therapy (MET), mechanical percussion, and diuretics can enhance stone passage and reduce analgesic needs 1
- Routine pre-stenting before ESWL does not improve stone-free rates but may reduce steinstrasse formation 1
Infectious Complications
Incidence:
- Bacteriuria develops in 7.7-23% of patients with non-infected stones 1
- Symptomatic bacteriuria occurs in 9.7% of patients, with Escherichia coli being the most common causative organism (30.4%) 2
- Sepsis is rare at 0.15% 1
Management:
- Perioperative antibiotic prophylaxis should be offered to all patients undergoing ESWL 1
- The choice of antibiotic prophylaxis should be tailored to institutional or regional antimicrobial susceptibility patterns 1
Tissue-Related Complications
Renal Complications:
- Asymptomatic hematoma occurs in 1.2% of cases 1
- Symptomatic hematoma develops in 0.21% of patients 1
- A decline in kidney function has been reported in small case series, particularly in children with primary hyperoxaluria, though this may reflect the natural disease course rather than ESWL-specific injury 1
Cardiovascular Complications:
- Cardiac dysrhythmias occur in 11-29% of patients 1
- In patients with pacemakers or defibrillators, ESWL is feasible with technical precautions; newer lithotripters may eliminate the need for reprogramming 1
Major Complications (Clavien Grade III-IV)
- Auxiliary procedures are required in 6-9% of cases 1
- Serious complications (Clavien grade III-IV) occur in 2.48% of patients 1
Long-Term Concerns
Hypertension and Diabetes:
- The link between ESWL and hypertension/diabetes remains unclear, with no conclusive evidence of long-term adverse effects 1, 3
- Current evidence does not support withholding ESWL based on diabetes concerns alone 3
Risk Mitigation Strategies
Technical Optimization:
- Decreasing shockwave frequency from 120 to 60-90 shockwaves per minute improves stone-free rates and reduces tissue damage 1
- Stepwise energy ramping minimizes renal injury 1
- Proper acoustic coupling between the treatment head and skin is crucial, as air pockets can deflect shockwaves 1
- Operator experience significantly impacts outcomes; better results are observed when ESWL is performed by experienced clinicians with precise imaging control 1
Special Populations and Contraindications
Absolute Contraindications:
- Pregnancy 1
- Bleeding disorders 1
- Uncontrolled urinary tract infection 1
- Arterial aneurysm near the stone 1
- Anatomic obstructions distal to the stone 1
High-Risk Bleeding Procedures:
- ESWL is classified as a procedure with high bleeding risk 1
- Patients with bleeding disorders or receiving antithrombotic therapy should be referred to an internist for appropriate therapeutic measures before proceeding 1
Critical Pitfalls to Avoid
- Avoid dehydration in the perioperative period, particularly in patients with primary hyperoxaluria, as even mild dehydration can lead to acute kidney injury 1
- Do not perform routine post-procedure stenting after uncomplicated ESWL, as this may increase morbidity without improving outcomes 1
- Recognize that ESWL has inferior outcomes compared to percutaneous nephrolithotomy for complex stones, particularly in primary hyperoxaluria patients where stone-free rates may be as low as 20-47% 1